Christoph Merten
EPFL Professor, Co-founder of TheraMe!
TheraMe!
Lausanne, Switzerland
About me
Prof. Christoph A. Merten is a professor for biomedical microfluidics at EPFL and holds an adjunct position at the Ludwig Institute for Cancer Research. In parallel, he has commercialized microfluidic technology and collaborated with big pharma. Christoph is a co-founder of TheraMe! and sole scientific founder of Velabs Therapeutics, now operating as Veraxa Biotech.
My organisation
Why going for a standardized cancer therapy if there are no standardized cancers? TheraMe! finds the best cancer treatment option, for each patient, at any stage of the disease.
Speaker sessions (1)
Tuesday, 10 December 2024
10:15 - 11:20
Pitch Sessions Healthtech
Experience the forefront of healthtech innovation at EPFL Investor Day!